Inactive Instrument

RushNet, Inc. Share Price Other OTC

Equities

RSHN

US7820741087

Business Support Services

Sales 2020 4.39M 350M Sales 2021 5.9M 471M Capitalization 4.5M 359M
Net income 2020 - 0 Net income 2021 - 0 EV / Sales 2020 2.75 x
Net Debt 2020 5.87M 468M Net Debt 2021 5.93M 473M EV / Sales 2021 1.77 x
P/E ratio 2020
13.3 x
P/E ratio 2021
55 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Operating Officer 43 01/08/21
More insiders
RushNet, Inc. operates under the name HeliosDX. HeliosDX is a national clinical reference laboratory offering high-complexity urine drug testing (UDT), behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease (PCR). The Company provides management services and insurance billing services principally to clinical reference laboratories. It provides PGX testing through Leo Partners. It provides oral fluid toxicology testing for a range of drugs. The Quantisal Collection Procedure makes taking the sample quick and easy. HeliosDX also offers a preliminary 10-panel plus adulteration detection screen, as well as confirmation testing via its comprehensive toxicology panel. Its subsidiaries include Chattahoochee Physicians Laboratory Services, LLC; doing business as HeliosDx and Grandeza Healthcare Consultants, LLC.
More about the company